A new class of medicines to address cancer and infectious diseases

Summary:

A Spanish biotech company dedicated to developing first-in-class novel Therapeutic Molecular Clusters (TMCs) has a pipeline of molecules with potent anticancer activity by several mechanisms of action and molecules active against bacterial and fungal pathogens protected by patents. TMCs freely diffuse across the blood brain barrier and into avascular structures with low levels of off-target toxicity. The company looks for research cooperation or commercial agreements with technical assistance.

Reference: TOES20210609003

Country: Spain

Submitted: 23. 7. 2021

View Partnering Opportunity

Keywords

Technology: Cytology, Cancerology, Oncology; Medical Technology / Biomedical Engineering; Pharmaceutical Products / Drugs.

Market: Oncology.

NACE: -

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.